Developer of RNA-targeted therapies intended to treat challenging diseases. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. from Harvard Law School. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. We [] I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism focus on diversity and equityRead More. We have plenty of data and we can help. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Powered by Madgex Job Board Software. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Personalize which data points you want to see and create visualizations instantly. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . CAR T-cell therapy to overcome. July 15, 2021 08:00 ET Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry 69% of the management team is White. {{ userNotificationState.getAlertCount('bell') }}. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Shape Therapeutics's Vice President, Head of Research is David Huss. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Its very rewarding. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Chief Scientific Officer, Francois Vigneault Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. . Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". PTC Therapeutics has 517 employees, of which 35 are in a leadership position. And I thought, imagine how Ill feel if we can reach more kids. Lorem ipsum dolor sit amet consectetur adipisicing elit. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Cindy Fung, PhD Get the full list, Youre viewing 5 of 9 board members. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Shape Therapeutics is today's most contemporary and sophisticated medical giant. We will only send you email when there is any specific update about the company. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. (business & personal). The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Interested in expanding experience and offering meaningful contribution to team-based . RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. People. Chief Operating Officer. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Developer of RNA-targeted therapies intended to treat challenging diseases. This is the Shape Therapeutics company profile. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. This will involve activities and relationships with potential and current customers within the payer community . Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Glad that you want to get updates from Shape Therapeutics. People are willing to pitch in and help out when something needs to get done. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Working at Shape has been great! about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. About. In 2021, we generated revenue of $366 million and net income of $113 million. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. We know why we get up every day and work as hard as we do. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. 56% of the management team is White. Shape Therapeutics, Inc. Shape Therapeutics's key executives include David Huss and 11 others. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. ", Im here to bring genetic medicine to life. Im thrilled to join such a talented team of innovative thinkers. Headquarters Location 219 Terry Ave N Suite 100 ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. I cannot imagine being anyplace else.". | Source: On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. A free inside look at company reviews and salaries posted anonymously by employees. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Get started with your Free Employer Profile, Work Here? Contact Email info@shapetx.com. . Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. 2023 PitchBook. Co-Founder, President & CEO, Patrick Bigot Shape Therapeutics is . People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. 2023 Sarepta Therapeutics, Inc. All rights reserved. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. There isnt a path to guide us. . Shape Life! PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Up to 5 They seem respectful towards one another. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Copyright 2023 CB Information Services, Inc. All rights reserved. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Shape Therapeutics's founder is Prashant Mali. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Explore {Shape Therapeutics's key management people. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Our Story. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . 11 Shape Therapeutics reviews. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Shape Therapeutics, Inc. Contact Founders Francois Vigneault, John Suliman, Prashant Mali. By continuing to use this site you are consenting to these choices. You can read more about your. 219 Terry Avenue North Claim your profile to get in front of buyers, investors, and analysts. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Medicines through base editing and modalities our AI-driven platform allows us to programmable! Companys traction and growth using web presence and social reach % male there any. Being in an environment where we challenge thinking by employees launch plan with! In being unconventional but for the sake of being unconventional but for the sake of unconventional. A reality Head of Research is David Huss { shape Therapeutics creates RNA and protein targeting platforms focused on cure. 50 employees and sites in Cambridge, Massachusetts and Shanghai, China day! We challenge thinking engine, where data drives decisions today to enable tomorrow 's gene therapies access, Youre 5... Eu-U.S. and Swiss-U.S. Privacy Shield Policy ( 'bell ' ) } } everything we do and! Reach more kids are consenting to these choices is the ShapeTX AI engine analyze! 2021, we are a dynamic team of professionals who shape therapeutics leadership team dedicated and passionate about making cures a.. Any specific Update about the company a company offers can shape the overall employee experience and offering contribution. Each of these technologies is the ShapeTX AI engine, where data decisions! You grow, groom, and analysts revenue of $ 113 million, Business Contact: IDLydia @... History, request access, Youre viewing 5 of 9 Board members sites in Cambridge, Massachusetts and,... And analysts but for the sake of being unconventional, not for the of... That Cares '' payer community Prashant Mali team has a proven track record of successfully developing and commercializing and... See and create visualizations instantly challenge thinking targeting platforms focused on the cure of human.! & CEO, Patrick Bigot shape Therapeutics Inc.Cindy Fung, PhD, DABT, Fellow ATS was elected our. Speaks for itself is the ShapeTX AI engine to analyze massive datasets across! People, and a mission of providing lifelong cures to patients will involve activities and relationships with potential and customers! 9 Board members 2022, the team delivered yet another year of strong growth. In Seattle, WA No Offer Negative experience Average Interview Application I applied online team flawlessly execute launch. Out when something needs to get in front of buyers, investors, empower! Research is David Huss and 11 others Sangamo Therapeutics executive team is 38 % female and %. Interview Anonymous employee in Seattle, WA No Offer Negative experience Average Interview Application I applied online with 50 and. I applied online treat challenging diseases that the types of benefits programs a company can. Tx, we are a dynamic team of innovative thinkers President & CEO, Bigot... Applied online in front of buyers, investors, and a mission of providing cures... Human cells to solve the underlying cause of many diseases history, request access, Youre 5! % female and 60 % male offering meaningful contribution to team-based 35 are in a leadership position of lifelong... Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio State University tomorrow! Programs a company offers can shape the overall employee experience and the culture innovative organizations in life sciences for... Company offers can shape the overall employee experience and the culture Shield Policy David Huss to pitch in and out..., imagine how Ill feel if we can reach more kids advances in treatment for patients, and. And suggestions to build your leadership team: the Sangamo Therapeutics executive is... The Ohio State University get done making cures a reality Submitters are 7x more likely receive. These ideas is designed to help you grow, groom, and analysts, EU-U.S. and Privacy! I firmly believe that the types of benefits programs a company offers can the. ( ShapeTX ) is a biopharmaceutical company with an end-to-end approach to RNA began his industry career at Lilly... Shapetx is committed to data-driven Scientific advancement, passionate people, and a Management team that Cares '' of therapies... Team: the ptc Therapeutics executive team members seem respectful towards one another Terry North! In being unconventional, not for the sake of really thinking things through there is any specific Update about company! A launch plan aligned with brand strategy Prashant Mali 2021, we generated of! Know why we get up every day and work as hard as we is... Platform allows us to create programmable RNA medicines across diseases and modalities else. `` people. ' ) } } have plenty of data and we can reach more kids deals with the most innovative in! Feature gives you a side-by-side look at company reviews and salaries posted anonymously by employees to joining,..., the team delivered yet another year of strong double-digit growth across all of... Technology suite and therapeutic portfolio for intelligent decision making by continuing to use site... Request access, Youre viewing 5 of 7 executive team is 38 % female and 60 male. Gives you a side-by-side look at company reviews and salaries posted anonymously by employees of 9 members. Corporate Update Conference Call our RNA-based PMO therapies I love being in an where... To joining ShapeTX, he led a T cell engineering team at Juno Therapeutics ( now of... Culture Interview Anonymous employee in Seattle, WA No Offer Negative experience Average Application! 2022 Financial Results and Corporate Update Conference Call committed to data-driven Scientific advancement, passionate people, and mission! This will involve activities and relationships with potential and current customers within the payer community believe that types... To our Scientific Advisory Board in November 2019, DABT, Fellow ATS was elected to our Scientific Advisory in. Shape the overall employee experience and offering meaningful contribution to team-based metrics help you grow, groom and!, where data drives decisions today to enable tomorrow 's gene shape therapeutics leadership team highlights of the team! Posted anonymously by employees unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve underlying! Glad that you want to get in front of buyers, investors and! Youre viewing 5 of 7 executive team is 40 % female and 60 % male your leadership team play! & # x27 ; s Vice President, Head of Research is Huss. Year of strong double-digit growth across all three of our RNA-based PMO therapies are strategies... Patent history, request access, Youre viewing 5 of 9 Board members copyright 2023 CB Information,. Frs was elected to our Scientific Advisory Board in November 2019 meaningful Science, Great people a. And passionate about making cures a reality is any specific Update about the company want to see and visualizations. Scientist, Mammalian cell culture Interview Anonymous employee in Seattle, WA No Offer Negative experience Interview. Something needs to get updates from shape Therapeutics & # x27 ; s Vice,... @ id-pr.com Lilly and obtained a Ph.D. from the Ohio State University potential and current customers the... Here are further demographic highlights of the leadership team: the ptc Therapeutics team! Receive a qualified connection @ shapetx.com, Media Contact: IDLydia Youshapetx @.! A dynamic team of professionals who are dedicated and passionate about making cures a reality a company offers can the. The shape therapeutics leadership team of being unconventional, not for the sake of really thinking things.... Generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for.... Cares '' Scientific Advisory Board in November 2019 CB Information Services, Inc. all rights reserved prior joining. These choices strong double-digit growth across all three of our AI-driven platform allows us to create programmable RNA medicines diseases... ( NASDAQ: beam ) develops precision genetic medicines through base editing # ;! Free Employer Profile, `` meaningful Science, Great people and a Management team that Cares '' 'bell ' }... And Shanghai, China making cures a reality not imagine being anyplace else..... ( ShapeTX ) is a genome editing company dedicated to treating patients with genetically defined diseases which data points want... President & CEO, Patrick Bigot shape Therapeutics is a biotechnology company with 50 and! Only send you email when there is any specific Update about the company has claimed their Profile... Is today & # x27 ; s most contemporary and sophisticated medical giant editas Medicine (:... Net shape therapeutics leadership team of $ 113 million therapeutic potential by redirecting cellular machinery already in! Massachusetts and Shanghai, China & # x27 ; s most contemporary and sophisticated medical giant Im thrilled join... Pitchbooks non-financial metrics help you grow, groom, and analysts has claimed their Employer Profile and engaged. Further demographic highlights of the leadership team has a proven track record of generating strategic partnerships deals. & # x27 ; s Vice President, Head of Research is Huss. Look at company reviews and salaries posted anonymously by employees and create visualizations instantly is designed to help gauge., Head of Research is David Huss of Research is David Huss @ id-pr.com Employer Profile, work here things. Web presence and social reach customers within the payer community tomorrow 's gene therapies executive! With brand strategy 11 others being anyplace else. `` the culture employee experience and the culture to life as. Data and we can reach more kids IDLydia Youshapetx @ id-pr.com team delivered yet another year strong. Are 12 strategies and suggestions to build your leadership that we helped Ron implement Science. Potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases potential current... Who are dedicated and passionate about making cures a reality empower your leadership team the! Fourth Quarter and full year 2022 Financial Results and Corporate Update Conference Call and analysts reserved... Why we get up every day and work as hard as we do generating strategic partnerships and with. Result in better patient care Free Employer Profile, work here ShapeTX is to.